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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need for 
standards to protect the health and safety of workers exposed to an ever- 
increasing number of potential hazards in their workplace. To fulfill this 
need, the National Institute for Occupational Safety and Health (NIOSH) has 
developed a urogram to assist employers in protecting the health of workers 
exposed to substances considered to have carcinogenic, mutagenic, or 
teratogenic potential. This program involves the development of Special 
Occupational Hazard Reviews which serve to support and complement the other 
maior standards development or hazards documentation activities of the 
Institute. It is the purpose of a Special Occupational Hazard Review to 
analyze and document the industrial health and safety problems associated 
with a given chemical or process, and to recommend the implementation of 
engineering controls and work practices designed to ameliorate these 
problems. While Special Occupational Hazard Reviews are not intended to 
supplant the more comprehensive NIOSH Criteria Documents, nor the brief 
NIOSH Current Intelligence Bulletins, they are nevertheless prepared in 
such a way as to be amenable to regulatory application if so desired. 
Special Occupational Hazard Reviews are made available to the occupational 
health community, trade associations, labor unions, industries, and the 
general scientific community for their evaluation and consideration for use 
in developing and implementing preventive measures ar̂ d identifying areas
for additional research. I I I
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SUMMARY AND CONCLUSIONS
Exposure to chrysene as an isolated chemical presently occurs only in 
specific occupations, i.e., chrysene synthesis, laboratory experimentation, 
and possibly in the synthesis of anthraquinone vat dyes. However, chrysene 
and its derivatives, e.g., certain methylchrysene isomers, along with 
hundreds of other polycyclic aromatic hydrocarbons (PAH's), are formed 
during the pyrolysis of organic matter and can occur in any occupational 
environment where this process takes place. While it has been suggested 
that 700 C is the optimum pyrolytic temperature for PAH-formation, other 
factors such as the chemical and physical nature of the pyrolyzed material, 
the presence or absence of oxygen, and the period of tine during which the 
compound is pyrolyzed also determine the amounts and mixtures of various 
PAH's formed. Chrysene has been detected in many materials which result 
from, or are used in,industrial processes. Chrysene also has been detected 
in the ambient atmosphere and in certain food products.
A number of experimental animal studies have been conducted for the 
purpose of assessing the carcinogenicity of chrysene, with varying results. 
When three 100(u)g doses of chrysene were administered by subcutaneous 
(s.c.) injection to newborn mice, an increased incidence of liver tumors 
was observed. The increase, however, was not statistically significant. 
Marginal results were obtained when mice were injected (s.c.) with 1 mg 
chrysene in arachis oil, once a week, for 10 weeks. This treatment 
resulted in the development of injection-site tumors in 2 of 20 animals.
Tumors also developed after chrysene (1% solution in acetone) was applied 
to the shaved backs of mice. Chrysene appears to exert a stronger 
carcinogenic effect when used as a tumor initiator than when used as a 
"complete" carcinogen, e.g., when the shaved backs of each of 20 mice were 
painted with ten doses of 0.1 mg chrysene (each in 0.1 ml acetone), 
followed by treatment with tetradecanoyl phorbol acetate (TPA) ,11 of the 
18 surviving mice had tumors (total of 19 tumors) after 20 weeks. Similar 
results were obtained using chrysene (total dose of 4.4 micromoles) either 
as an initiator with TPA, or when chrysene (1.0 mg in 0.4 ml acetone) was 
painted on the shaved backs of mice prior to treatment with croton resin. 
Chrysene also has produced positive results in mammalian cell 
transformation tests and in the "Ames" test for mutagenicity.
Certain methylchrysene isomers have also been shown to possess 
carcinogenic potential: 5-methylchrysene has been reported to be a strong 
"complete" carcinogen as well as a stronger tumor initiator than chrysene. 
Epidemiologic evidence for the carcinogenicity of chrysene as an isolated 
chemical was not located. However, certain industry-related materials 
which contain many PAH's, including chrysene and its methyl derivatives, 
have been linked with cancer induction in humans. A historical review of 
these occurrences can be found in the preamble of International Agency for 
Research on Cancer (IARC) Monograph, Volume 3 (1973) .
While the evidence is not conclusive, the positive results obtained in 
certain animal studies, coupled with the demonstrated biochemical activity 
of chrysene and its presence in materials which have been found to be
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carcinogenic to humans, indicate that chrysene should be regulated as a 
potential occupational carcinogen.
Control measures recommended in this report are designed for chrysene 
work areas, i.e., areas where the isolated chemical is manufactured, used, 
or stored. These control measures include: primary emphasis on
engineering controls, e.g., process enclosure and local exhaust 
ventilation, where technologically feasible; use of personal protective 
equipment, e.g., coveralls, rubber gloves, and appropriate respirators; 
posting of warning signs; provision for medical surveillance; institution 
of spill-disposal procedures; and recordkeeping.
Chrysene may be generated inadvertently in numerous industrial 
processes which involve the pyrolysis of organic matter. Further, 
conditions which are favorable for the formation of chrysene also are 
likely to be favorable for the formation of methylchrysenes and numerous 
other PAH's whose carcinogenic potencies range from greater than to less 
than that of chrysene. While the aforementioned control measures may be 
applied to the general class of PAH's, NIOSH recognizes that under certain 
circumstances of PAH-exposure, they will be neither appropriate nor 
feasible.
While no workplace environmental limit for chrysene is recommended at 
this time, information on analytical methodology is included in this 
review. Most methods for the identification and quantitation of chrysene 
involve various forms of chromatography and spectrometry.
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INTRODUCTION
The carcinogenic potential of certain polycyclic aromatic hydrocarbons 
(PAH's), e.g., benz(a)pyrene and benz(a)anthracene, has been well 
documented (IARC Monograph, Volume 3, 1973; Dipple, 1976). However,
comparatively little information exists upon which to base an evaluation of 
the carcinogenic potential of chrysene. Further, isolated exposure to 
chrysene occurs only in specific operations, i.e., chrysene manufacture, 
laboratory experimentation, and possibly in the synthesis of anthraquinone 
vat dyes. The number of workers thus exposed is small relative to the 
number of workers exposed to chrysene ad-mixed with other PAH's in 
industrial processes which involve the pyrolysis of organic matter. This 
notwithstanding, sufficient quantities of chrysene may now be in use to 
elicit concern over any biological effects exerted by this chemical. Thus, 
an integration and evaluation of all experimental data pertinent to the 
carcinogenic potential of chrysene appears warranted.
There is now no federal occupational health standard for chrysene, or 
for any other individual PAH. Nor has the American Conference of 
Governmental Industrial Hygienists (ACGIH) recommended Threshold Limit 
Values (TLV's) for individual PAH's. Concern for occupational exposure to 
PAH's as a class is reflected, however, in the federal occupational 
exposure limit for Coke Oven Emissions (29 CFR 1910.1029) of 0.15 
milligram/cubic meter of air (mg/cu m) measured as the benzene-soluble 
fraction of total particulate matter (BSFTPM) and as a time weighted
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average (TWA). In addition, the ACGIH (1976) has recommended a TLV-TWA of
0.20 mg/cu m (as BSFTPM) for both coal tar pitch volatiles (CTPV) and 
particulate polycyclic aromatic hydrocarbons (PPAH) . Completed NIOSH
criteria documents on asphalt fumes, and coal tar products also address PAH 
exposures, as will future criteria documents on the roofing industry, 
carbon black, and welding and brazing. It also should be noted that the
criteria document on coal tar products contains a recommendation for a
permissible exposure limit of 0.1 mg/cu m measured as the cyclohexane- 
soluble fraction of total particulate matter (CSFTPM) .
The Federal coke oven standard, the ACGIH TLV's, and the NIOSH 
recommended standards, all deal with PAH’s from particular sources.
Different sources produce various amounts and mixtures of PAH's, and the 
individual PAH's have considerable ranges of toxicity. Adequate assessment 
of the hazards from occupational exposure to the general class of PAH's, 
and development of effective standards for worker protection probably will 
require their handling on a process basis.
A review of the health hazards associated with chrysene and some of its 
derivatives, i.e., methylchrysene isomers, follows. General
recommendations are included for control of occupational exposure in 
chrysene work areas, i.e., areas where chrysene is manufactured, used, or 
stored. Chrysene is merely one of many PAH's (which have wide ranges of 
toxicity) generated inadvertently in certain occupational environments, and 
the control recommendations included in this document may be applicable to
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many PAH's, regardless of their source or fractional content. However, 
NIOSH recognizes that this will not necessarily be the case under all 
circumstances of PAH-exposure. The information and recommendations will 
aid the U.S. Department of Labor, industrial hygienists, occupational 
physicians, and employers in providing workers with protection from the 
hazards of exposure to chrysene. They also will aid workers in recognizing 
these hazards so that individual protective action may be taken.
I. PROPERTIES AND CHARACTERISTICS OF CHRYSENE
A. Identification




2. CAS number: 000218019 K-Region
3. Formula: C18H12 \




1. Appearance and odor: colorless and odorless platelets,
i.e., solid at STP in pure reagent form
2. Boiling point: 448 C (at 760 mm Hg)
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3. Melting point: 254 C
4. Specific gravity: 1.274
5. Solubility: insoluble in water; slightly soluble in alcohol,
ether, carbon disulfide, glacial acetic acid; soluble in 
benzene.
II. COMMON OPERATIONS, USE, AND OCCURRENCE 
A'. Workplace Environment
PAH's are perhaps the most ubiquitous of the carcinogenic agents that 
have been detected in the atmosphere. Chrysene, along with other PAH's, 
occurs most frequently as an adsórbate on airborne particulates resulting 
from the pyrolysis of carbonaceous materials (Filatova et al., 1972).
Chrysene is sometimes encountered as a vapor. The yield of chrysene can be 
affected by the chemical and physical nature of the pyrolyzed compound, the 
pyrolysis temperature, the presence or absence of adequate oxygen for 
complete combustion, and the period of time during which the compound is 
exposed to heat. Experimental determinations have shown the optimal 
temperature for PAH formation to be around 700 C (Masuda et al., 1967). 
From an occupational health standpoint it is important to identify the 
sources of these compounds. Table I lists some of these sources for 
chrysene.
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TABLE I. SOURCES AND CONCENTRATIONS OF CHRYSENE FOUND IN WORKPLACE ENVIRONMENTS
Source
Particulate matter, catalyst regeneration 
flue gas of an oil refinery
Coal tar pitches from coke oven production





Effluent from tar-fired retorts in a 
gas-producing plant
Carbon black
Soot from brick kiln exhaust
Smoke from burning wood
Concentration*
12.000 ppm
7400 ppm and 10,000 ppm 
7000 ppm
2130 and 2860 ppm 





0.58 ppm of 
sawdust burned
Reference
Sawicki et al., 1965
Wallcave et al., 1971 
Sawicki et al., 1965 
Lijinsky et al., 1963 
Lijinsky et al., 1963 
Wallcave et al., 1971 
Cleary, 1963
Qazi and Nau, 1975
Cleary, 1963
Rhee and Bratzler, 1968
TABLE I. SOURCES AND CONCENTRATIONS OF CHRYSENE FOUND IN WORKPLACE ENVIRONMENTS (continued)
Petrolatums
Certain organic solvents derived from 




Resinous substances from air in coke and 
metallurgical plants
Extracts from bituminous coal prior to 
pyrolysis
Stack gases from sulfate pulping mill
Extracts of processed rubber stoppers and 
automobile tires




Lijinsky et al., 1963 
Lijinsky and Raha, 1961
Filatova et al., 1972
Tye et al., 1966
Hendrickson et al., 1963 
Falk et al., 1951
*Unless otherwise stated, the units (ppm) refer to parts of chrysene per 
million parts of source material sampled, as a weight/weight ratio.
B. Occupational Areas of Concern
At present, it is believed that exposure to chrysene as an isolated 
chemical occurs only in specific occupations, i.e., in chrysene 
manufacture, laboratory experimentation, and perhaps in the synthesis of 
anthraauinone vat dyes. It was Holbro (1953) who suggested the use of 
chrysene as a starting material in the synthesis of dyestuffs, particularly 
of anthraquinone vat dyes, to which the results of his research showed 
chrysene imparted favorable properties regarding "affinity, shade, and 
fastness". While the scope of this report is limited primarily to chrysene 
as an isolated chemical, its occurrence with other PAH's in a wide range of 
occupational environments cannot be disregarded.
The following list of occupational areas, where worker exposure to 
chrysene and other PAH's is likely to occur, is separated into stationary- 
point and non-stationary point source categories: the former refers to 
inplace operations, i.e., where engineering controls could be expected to 
substantially reduce employee exposure, and the latter refers to outdoor or 
mobile operations where the application of engineering controls may be more 
difficult. In the latter case, however, it would be expected that natural 
factors (wind, etc.) would contribute to reductions in worker exposure. 
While this list is based on the occurrence of chrysene as it has been 





Carbon black manufacturing operations
Charcoal manufacturing operations
Coffee roasting operations
Coke oven operations (refer to Federal Standsr‘ 
on Coke Oven Emissions)
Grill cooking operations 
Iron foundry operations 
"Liquid smoke" production 
Municipal incinerator operations 
Petroleum cracking operations 
Rubber processing operations 
Sintering mill operations 
Smokehouse operations 
Sulphate paper pulping mills 
Wood preservative treatment processes
Non-stationary point sources
Acetylene-torch cutting and brazing operations
Airport runway operations
Bus terminal operations (boarding areas)
Diesel trucking operations
Furnace maintenance and repair operations
Gasoline station and automobile repair operations
Stationary point sources
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Heavy equipment operations, e.g., tractors, cranes 
and earth-movers 
Road paving and sealing operations 
Roofing operations 
Street sweeping operations 




Chrysene is found in the general environment primarily as a product of 
the pyrolysis of fossil fuels for energy production and the operation of 
diesel- and gasoline-fueled internal combustion engines.
Chrysene has been measured in the atmospheres of several major cities. 
In Sydney, Australia, a 12-month survey of the ambient PAH content of 
suspended particulate matter showed chrysene at concentrations ranging from 
0.0002 to 0.0065 (u)g/cu m of air (Cleary and Sullivan, 1965). Chrysene 
was found in the atmosphere of Buffalo, New York, at concentrations of 
0.082-0.116 (u)g/cu m of air, and in composite samples from the air of 
urban Cincinnati, Ohio at concentrations of 0.0032 and 0.006 (u)g/cu m of 
air CCcnlee et al., 1967).
Studies have been conducted to determine the contribution of the 
gasoline engine to atmospheric levels of PAH's. Gasoline engine exhaust
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tar was found to contain 175 ppm chrysene (Hoffman and Wynder, 1962). In 
another investigation, the PAH emissions from diesel- and gasoline-powered 
vehicles were compared (Sullivan and Cleary, 1964), and chrysene was found 
in a diesel-trafficked area at a concentration of 0.0032 (u)g/cu m of air; 
in the gasoline-trafficked area, chrysene was found at a concentration of 
0.0034 (u)g/cu m of air.
In addition to the finding of chrysene in ambient air, its presence in
soil and water has been substantiated. Although quantitative data are few, 
chrysene has been identified in soils in rural Massachusetts and 
Connecticut (Blumer, 1961), and in wells, rivers, lakes, and soils in 
Germany (Borneff, 1964; Borneff and Kunte, 1965). One investigator 
suggested that the occurrence of chrysene and other PAH's in rural soil is 
not due to fallout from polluted air but, rather, is the result of the 
natural pyrolytic transformation of plant organic matter to peat and 
lignite; or that alternatively, they occur as metabolites of organisms
which reside in the soils (Blumer, 1961).
Chrysene also has been detected in certain food products: roasted
coffee (Kuratsune and Hueper, 1960), spinach and tomatoes (Grimmer and 
Hildebrand, 1965), baker's yeast (Grimmer and Wilhelm, 1969), "liquid 
smoke" (Lijinsky and Shubik, 1965), smoked ham and barbecued beef 
(Malanoski et al., 1968), charcoal-broiled steak and chicken (Lijinsky and 
Ross, 1967), and electric-broiled fish (Masuda et al., 1966).
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Of particular importance is the occurrence of chrysene in cigarette- 
smoke condensate. Chrysene has been found in cigarette-smoke condensate at 
a concentration of 0.06 (u)g per 100 cigarettes (Van Duuren, 1958). 
Cigarette smoke may add significantly to the total exposure to chrysene 
from both the general environment and work environment.
III. BIOLOGICAL EFFECTS OF EXPOSURE
A. Toxic Effects in Animals
Schmid et al. (1967) used mortality and body and organ weight changes 
in mice as measures of chrysene toxicity. Each of 10 male AKR and 10 male 
C57BL/6 mice was given a single i.p. injection of 7.5 mg chrysene dissolved 
in 1 ml of sesame oil. All animals were alive after 20 days of observation 
at which time they were killed. Autopsies revealed that none of the mice 
had experienced any significant change in body, spleen, or thymus weight. 
The investigators concluded that chrysene was not toxic as reflected by the 
aforementioned parameters and experimental conditions.
Gershbein (1958) tested the effects of chrysene on liver regeneration 
in partially hepatectomized adult male Sprague-Dawley rats. Single s.c. 
injections of 12.0 mg chrysene in peanut oil were given daily for the 11- 
day test period to each rat (320 mg/kg body weight). This treatment caused 
no significant change in the extent of liver regeneration from that in the 
corresponding controls.
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Bernheim et al. (1953) found that a 0.3% solution of chrysene in 
benzene, when painted on the skins of white mice, inhibited fatty acid 
peroxide-induced thiobarM ■ -».ric acid-color development on the epidermal 
side, but did not in the subcutaneous fat. The investigators attributed 
these results to inhibition of fatty acid oxidation. They noted that 
oxidized fatty acids are more effective inhibitors of certain enzymes and 
of bacterial growth than are the corresponding unoxidized acids, so that a 
carcinogen, by inhibiting peroxide formation, might produce conditions 
favorable for growth. They also suggested that inhibition of fatty acid 
oxidation may be a necessary, but certainly not a sufficient, condition for 
tumorigenesis.
B. Carcinogenicity in Animals
A number of experimental animal studies of the carcinogenic potential 
of chrysene have yielded varying results. Most of these studies have been 
conducted with mice, and various investigators have described chrysene as a 
weak carcinogen (Wynder and Hoffman, 1959); a cancer "initiator" (Hoffman 
et al., 1974); an "incomplete" carcinogen (Horton and Christian, 1974); and 
as a cancer "inhibitor" (Huggins et al., 1964). The following experimental 
results illustrate the variability in reported carcinogenic activity of 
chrysene.
Grover et al. (1975) tested the carcinogenicity of chrysene and 
chrysene 5,6̂ -oxide (an epoxide), in newborn Swiss mice (Table II.A.), from 
a specific pathogen-free breeding colony. The mice were each injected
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TABLE II. SUMMARY OF SELECTED EXPERIMENTS TO ASSESS THE CARCINOGENICITY OF CHRYSENE
MICE, newborn Swiss. Route of 




no. of total mice 
treatments inlected (M&F)
no. mice 









liver multiple lung multiple other
tumors liver tumors tumors lung tumors tumors
Chrysene 100(u)g 3 104 51, 29, 22 27 M 13 6 1 1 0
21 F 0 0 1 0 0
Chrysene 5,6-oxide 100(u)g 3 107 47, 24, 23 21 M 8 3 0 0 0
20 F 1 0 0 0 0
PEG 400 (controls) _ 3 96 52, 34, 18 30 M 9 1 3 1 0
15 F 0 0 1 0 0
B. MICE, C 57 black. Route of exposure: Subcutaneous injection
(Boyland and Sims, 1967)
number of 
injections x
number of animals 
surviving until the 
appearance of the number of
time of first appearance 
of tumors (in days after
Compound dose in mg first tumor sex animals with tumors first inlection)
Chrysene 10 x 1 20 M 2 248 and 262
Chrysene 5,6-oxide 10 x 1 20 M 3 189, 284, and 303
Arachis oil 
(controls)
10 x 1 20 M 0 -
. MICE, CD-I. 
(Scribner,
Compound





dose of TPA 
in (u) moles
animals per 
group tumor incidence, papill omas/mouse (% mice with tumors) (wk)
survivors 
35 wk.
10 1¿ 20 25 30 15
Chrysene 4.4 10 30 0.33 2.03 
(20) (60)
3.27 3.07 2.83 2.87 
(73) (77) (67) (73)
29
none - 10 30 0 0 
(0) (0)
0 0.03 0 0 
(0) (3) (0) (0)
30
*TPA - tetradecanoyl phorbol acetate, applied, after chrysene, as a "promoter."
TABLE XI: SUMMARY OF SELECTED EXPERIMENTS TO ASSESS THE CARCINOGENICITY OF CHRYSENE (continued)
D. MICE, ICR/HA Swiss. Route of exposure: Skin application
(Van Duuren et al., 1966)
primary (single dose)
Chrysene, 1 mg in 
0.4 ml acetone
Chrysene, 1 mg in 
0.4 ml acetone
secondary dose per animal 
(i times weekly)_______
croton resin, 25(u)g in 
0.1 ml acetone




days to first: 
papilloma cancer
125 411
survivors at end weeks












E. MICE, C3H. Route of exposure: Skin application













1 i1 (voi) 2 X 60











number of mice 
with tumors













F. MICE, C57 black. Route of exposure: Subcutaneous injection








5.0 mg in 
0.5 cc 
tricaprylin
5.0 mg in 
0.5 cc 
tricaprylin
2.5 mg each, 
in 0.5 cc 






no. of mice surviving no. of induced





















(s.c.) with 100(u)g of a test chemical, on each of the first 3 days of 
life. The test compounds were administered as 0.02 ml suspensions using 
polyethylene glycol (PEG) 400 as the vehicle. Surviving mice were weaned 
at 21 days of age and observed for 70-75 weeks. Of the 48 survivors at 70 
weeks in the chrysene-treated group, liver tumors were observed in 13 (6 of 
which had multiple tumors) and lung tumors were seen in 2 (one of which had 
multiple tumors). Of the 45 chrysene 5,6-ox:Lde-treated survivors at the 
end of 70-75 weeks, 9 had developed liver tumors (3 of which had multiple 
tumors). With the PEG 400 vehicle controls, of the 45 mice surviving to 70 
weeks, 9 had liver tumors (1 of which was multiple) and 4 mice had lung 
tumors (1 of which was multiple). The investigators concluded that 
chrysene seemed to be a more active tumorigen than its epoxide, and that it 
increased the incidence of liver tumors above that in the controls, while 
the epoxide did not do so, and that neither chrysene nor the epoxide 
affected the incidence of lung tumors. The liver tumors ranged in 
appearance from well differentiated liver cell masses that were difficult 
to distinguish from normal liver tissues to those exhibiting pleomorphism, 
invasion, and metastasis. The increased incidence of liver tumors after 
exposure to chrysene, however, was not statistically significant (P=0.05).
Boyland and Sims (1967) conducted a similar experiment with chrysene 
and chrysene 5,6-oxide (Table II.B.). C57 black mice, 120 days old, were
injected s.c. with 1.0 ml suspensions of arachis oil that contained 1.0 mg 
of either chrysene or chrysene 5,6-oxide, once/week, for 10 weeks. A third 
group, given only arachis oil, served as the control. After an observation 
period ranging from 60 to 80 weeks, 2 of the 20 chrysene-treated mice
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surviving at the time of observation of the first tumor (initial number of 
animals treated was not stated) had developed injection-site tumors. A 
comparable number of animals (3 of 20) developed injection-site tumors from 
the epoxide but the time-to-tumor was longer by an average of 8.6 days. 
Because of the longer latency period for the epoxide, the investigators 
concluded that the parent PAH was a more active tumorigen. None of the 
control animals had tumors. Of the tumors induced by the active compounds, 
about 80% were spindle-cell sarcomas, about 12% were pleomorphic sarcomas 
and about 8% were squamous cell carcinomas.
Wynder and Hoffman (1959) applied a 1% solution of chrysene in acetone 
to the backs of female Swiss (Millerton) mice, three times weekly until the 
last animal died (sometime during the 13th month of treatment). Nine of 
the original 20 animals had developed papillomas and 8 had developed 
carcinomas, with the first tumor appearing after 8 months of treatment. 
From the original data it is not possible to determine with exactitude the 
number of animals with both papillomas and carcinomas. A decrease in 
lifespan was also noted; no controls were included in the experiment. It 
is unlikely, however, that such a high incidence of carcinomas would occur 
spontaneously in this strain of mouse.
Several investigators have shown chrysene to act as a cancer 
"initiator." Hoffman et al. (1974) tested the tumor-initiating activity of 
chrysene and of six of its methyl derivatives. The purities of the test 
substances were greater than 99.9 %. Ten doses of 0.1 ml of acetone each 
containing 0.1 mg of the test PAH (total dose, 1.0 mg) were applied on
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alternate days to the shaved backs of each of 20 female Swiss albino mice 
(Ha/ICR/Mil). Application of the "promoting" substance, tetradecanoyl 
phorbol acetate (TPA) was begun 10 days following the last PAH-treatment. 
TPA, in doses of 2.5 (u)g in 0.1 ml of acetone, was applied three times a 
week for 20 weeks, for total doses of 0.15 mg. Acetone alone (10 doses of
0.1 ml) served as a control treatment and was reported to have produced 
negative results in a separate group of mice, although no quantitative data 
were given. In the chrysene-exposed group, after 20 weeks of TPA 
applications, 11 of the 18 surviving mice had a total of 19 tumors. The 3- 
methyl- and especially the 5-methylchrysene were even stronger tumor 
initiators than was chrysene, with 14 of 20 surviving mice sharing a total 
of 26 tumors , and 17 of 20 surviving mice sharing a total of 96 tumors, 
respectively. Each compound was concurrently bioassayed for "complete" 
carcinogenicity in mice of the same strain and sex. Solutions of 0.1 mg of 
each material in 0.1 ml acetone were applied under identical conditions to 
the shaved backs of the animals, three times weekly for the duration of the 
experiment. After 30 weeks, 5-methylchrysene showed high carcinogenic 
activity. Each of the 20 mice had tumors (with a total of 99 tumors), 
including 12 with 37 carcinomas, and 2 with multiple métastasés to the 
lungs and spleen. Chrysene and the other five methylchrysenes showed no 
significant tumorigenic activity according to the investigators. 
Quantitative data for chrysene and for the control vehicle were not given.
Hecht et al. (1976) also tested 5-methylchrysene for "complete" 
carcinogenicity via two routes. Ten s.c. injections of 0.05 mg 5- 
methylchrysene in trioctanoin (0,1 ml each injection) were given to each of
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25 male C-57 black mice at 2-week intervals, after which the animals were 
observed for 32 weeks. This exposure to 5-methylchrysene resulted in 24 
fibrosarcomas in 22 animals, with the first tumor appearing at 25 weeks. 
Vehicle controls had no tumors. In addition, 5-methylchrysene was compared 
with benzo(a)pyrene (BaP) for tumor-initiating potential and "complete" 
carcinogenicity on mouse skin. For the tumor-initiating tests, ten 
initiator doses of 3 (u)g of 5-methylchrysene dissolved in acetone were 
applied to the skins of 20 female Swiss mice (Ha/IQR) during the second 
resting phase of the hair growth cycle. "Promotion" was accomplished by 
applying 0.1 ml of a 0.0025% solution of TPA in acetone thrice weekly for 
20 weeks. Benzo(a)pyrene was tested similarly. The results indicated that 
5-methylchrysene was a stronger tumor initiator than BaP; application of 
the former compound resulted in a total of 45 tumors in 20 mice (including 
1 mouse with 1 carcinoma), whereas exposure to the latter resulted in a 
total of 6 tumors (no carcinomas) in 6 mice. The latency period for both 
groups was 5 weeks. None of the control mice had tumors. Each chemical 
was also applied thrice weekly at concentrations of 0.01% and 0.005% in 0.1 
ml acetone to the shaved skins of 20 mice. After 55 weeks of exposure to 
5-methylchrysene, 15 mice bore 38 tumors, including 10 mice with 12 
carcinomas. Comparable results were seen in the BaP-treated mice. The 
control mice (solvent alon?) developed no tumors. The investigators 
suggested that the demonstrated carcinogenicity of 5-methylchrysene may 
have resulted from the high electron densities at its 5-6 and 11-12 K- 
regions due to the electron-releasing effect of the methyl group; the high 
electron density might facilitate either metabolic activation to an
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"ultimate" carcinogen or detoxification. (See additional discussion 
below.)
Scribner (1973) (Table II.C.), showed chrysene to produce multiple 
papillomas when used in small doses as an initiator. The backs of 30 
female CD-I mice, 8 weeks old, were shaved and treated 2 days later with 
chrysene in acetone (total chrysene dose, 4.4 (u) moles). One week later, 
a twice-weekly treatment with TPA was begun. At the end of 35 weeks, 73% 
of the 29 survivors had developed papilloiiVnS, whereas the control group 
(TPA only) had developed none.
Similar results had been obtained by Van Duuren et al. (1966) when, in 
order to test its cancer-initiating potential, they applied chrysene in 
doses of 1.0 mg (in 0.4 ml of acetone) to the shaved backs of 20 female
ICR/HA Swiss strain mice (Table II.D). A known tumor promoter, croton
resin, in doses of 25.0 mg (in 0.1 ml of acetone) was applied to the same 
mice beginning 13-21 days after the chrysene treatment and thrice weekly 
thereafter. This combined treatment resulted in papillomas in 16 of 20
mice and carcinomas in 2 of 20 mice, with the first observation of the
former after 125 days and of the latter after 411 days of the 63-week 
experiment. Controls receiving only croton resin showed a much lower 
incidence of tumors (5 benign, 1 malignant), The authors stated that 
previous experimentation with this substance alone by other investigators 
had resulted in no malignancies. The investigators concluded that chrysene 
acts as a "notable" cancer- initiating substance. In the same experiment,
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exposure to chrysene alone failed to result in the development of tumors in
mice.
Other investigators have found evidence that chrysene may act 
synergistically with certain susbtances to induce tumorigenesis. Horton 
and Christian (1974) found that a 0.15% solution of chrysene in 
decahydronaphthalene (Decalin), a "non-carcinogenic" agent, when painted on 
the backs of 20 C3H male mice (60 (u)l doses, 2 x week), induced a 
papilloma in 1 of 12 surviving animals after 76 weeks of treatment (Table
II.E.). However, when chrysene was applied in a 0.15% solution with a 
50:50 Decalin: n-dodecane mixture (a known co-carcinogenic mixture) to the 
backs of 20 mice, 12 and 5 out of 19 surviving animals developed papillomas 
and carcinomas, respectively. The median time for tumor induction was 49 
weeks. The effects of n-dodecane alone were not tested for. The authors 
classified chrysene as an "incomplete" carcinogen, i.e., one lacking the 
co-carcinogenic activity of a strong "complete" carcinogen.
Steiner and Falk (1951) studied the carcinogenic activity of chrysene 
in combination with 1,2-benzanthracene (Table II.F.). The actions of 
chrysene and of 1,2-benzanthracene were first tested separately. Fifty C57 
black mice, 3-4 months old and in about equal numbers of males and females, 
were injected s.c. with 5.0 mg chrysene in 0.5 cc tricaprylin. There was 
a total of 4 injection-site sarcomas among the 24 surviving mice for a 
tumor incidence of 16.6 % compared with a 1.3 % incidence of tumors in the 
tricaprylin controls and a zero incidence in the uninjected controls. The
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investigators considered the results to have shown that chrysene has a 
definite carcinogenic potential. A tumor incidence of 18.2 % was seen
after the administration of 1,2-benzanthracene with the average induction 
time of 285 days. A mixed solution of the two PAH's (2.5 mg each) in 
tricaprylin was then administered to each of 50 mice in a like manner. The 
tumor incidence from this dose was 44.1%. Because this incidence was a 
little greater than the summation of the individual responses at full 
doses, the investigators concluded that the results were demonstrative of 
either summation or synergism.
In a follow-up study by Steiner (1955) , a mixture of the "strong" 
carcinogen 1,2,5,6-dibenzanthrene with chrysene, when administered s.c. to 
approximately fifty C57BL mice, showed no significant additivity of
effects, i.e., the incidence of tumors was the same as for either agent
alone, and the question was raised by the investigator as to whether there
had not been actual inhibition of tumorigenesis.
Huggins et al. (1964) attempted to detect any inhibitory effects of 
chrysene upon the action of a more potent carcinogen. In these
experiments, 2 mg i.v. injections of 7,12-dimethylbenz(a)anthracene (7,12- 
DMBA) were given to each of 74 rats on days 50, 53, and 56 of their lives. 
Mammary tumors resulted in all 74 animals (100%) . A separate group of 
animals was given (gastric intubation) single doses of chrysene (40 mg) 
followed by the same 7,12-DMBA treatment. These animals showed no 
significant change in the incidence of mammary tumors. However, in another 
group of test animals, multiple doses of chrysene (15 mg x 16 days) during
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a period that overlapped i.v. injections of 7,12-DMBA greatly reduced the 
incidence of mammary tumors (60% vs 100%) .
Riegel et al. (1951), painted a mixture of chrysene (15%) and
methylcholanthrene (15%) in acetone on the shaved backs of CF1 mice (0.02 
ml of test solution, twice weekly, for 31 weeks) and compared its 
carcinogenic activity with that of methylcholanthrene (15% in acetone) 
alone. In the group treated only with methylcholanthrene, 23 of 28 animals 
(82%) developed tumors after a mean latent period of 14.1 weeks. In the 
group painted with the chrysene/methylcholanthrene mixture, 17 of 20 
animals (85%) developed tumors after a mean latent period of 13.8 weeks. 
Mean latent periods were calculated from the day that painting with the 
mixture was begun. From these results,, the investigators concluded that 
chrysene had no significant inhibitory effect on the carcinogenicity of 
methylcholanthrene. Similar applications of 0.20% chrysene in acetone to
20 mice resulted in one tumor among 16 survivors at 31 weeks.
In addition to the positive animal test results, indirect evidence for 
the carcinogenicity of chrysene can be derived from results with two
different in vitro test systems.
McCann et al. (1975) reported that both chrysene and chrysene-5,6-oxide 
were mutagenic in the Ames test. This test utilizes the organism,
Salmonella typhimurium, to indicate DNA damage, and mammalian liver 
extracts for metabolic activation of the test chemical. Chrysene was 
tested on strain TA100 and resulted in 38 revertants per nanomole. The
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investigators noted that the relationship between the.mutagenic potency of 
a substance on a particular strain to its overall mutagenic potential on 
DNA in general, and to carcinogenic potency, remained to be determined.
Huberman et al. (1972) tested the effects of chrysene (15.0 (u)g/ml for 
4 hours) on Syrian hamster embryo cells in culture and found definite dose 
dependent increases in the numbers of "malignant" transformations in 
exposed cell colonies. Also, it was found that chrysene 5,6-oxide (15.0 
(u)g/ml) was even more active in producing transformations. Similar 
relationships were observed between other PAH's and their epoxides. For 
this reason, and because such epoxides had been shown to be metabolic 
intermediates of PAH's, the investigators postulated that the epoxides are 
possibly the ultimate carcinogenic forms of at least those PAH's that do 
not contain active methyl groups.
In a follow-up to the 1972 study of Huberman et al., Huberman and Sachs 
(1976) tested chrysene, in the presence of enzymes required for its 
metabolic activation, on Chinese hamster cells in culture (2-day treatment 
at 1(u)g/ml/day). Chrysene showed negligible mutagenic activity (9 mutants 
for chrysene vs 6 mutants for solvent alone, per 10,000 surviving cells).
Negative results were also obtained by Marquardt et al. (1972) who 
tested the ability of chrysene and its epoxide (1.0-10.0 (u)g/ml doses for 
each) to transform cells derived from mouse prostate.
According to other investigators, the primary process in cancer 
induction (by PAH's) involves binding to a cellular component, e.g., DNA, 
ENA, or protein, at the K-region of the PAH (Raha et al. 1973). Typically,
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the K-region of a PAH is a highly reactive site. Experimentally measured 
bond lengths, chemical reactivities, and valence-bond and molecular orbital 
calculations all agree in assigning a higher electron density to the K- 
region than to any other bond in the PAH molecule (Herndon, 1973) .
C. Toxic Effects in Humans
No reports concerning the toxicity of chrysene in humans were located. 
Considerations for any toxic effects of chrysene in humans would primarily 
be concerned with inhalation of particulate matter, since chrysene is 
encountered most frequently as an airborne particulate or as an adsórbate 
on airborne particulates. The occurrence of any biological effect would be 
closely related to the physical characteristics of the particle. Particle 
size predominantly determines the extent to which penetration of (and 
retention by) the tracheobronchial tree will occur, with maximum retention 
falling within an aerodynamic particle size range of 0.5 to 2.0 microns 
(Kotin and Falk, 1964) . Ingestion and skin absorption must also be 
considered potential routes of exposure. Further, it should be noted that 
small amounts of chrysene-containing particles might be ingested following 
their inhalation as particles and mucus reflux from the bronchial tree 
(Hill et al., 1972) .
No epidemiologic studies concerning the carcinogenicity of chrysene per 
se were located in the literature. The carcinogenic potential of chrysene 
in humans must therefore be estimated on the basis of animal studies or be 
deduced from experiences with mixed exposure to chrysene and other PAH's.
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D. Summary of Carcinogenicity Data
While it is clear that exposure to PAH's is associated with increased 
risk for both lung and skin cancer in humans, the relative contribution of 
individual compounds is difficult to determine. Chrysene is a component in 
virtually all occupational exposures to PAH's. In order to assess the 
specific carcinogenic potential of chrysene, evidence based mainly on 
animal experiments, and supported by in vitro test results, must be 
utilized.
Evidence of chrysene's carcinogenic potential has come primarily from 
experiments in which the isolated chemical (and certain derivatives) was 
administered to animals by skin painting or by s.c. injection. Chrysene 
also has been shown to be active in some mammalian cell culture tests and 
in microbial assays for mutagenicity.
Certain generalizations can be made regarding the tumorigenic potential 
of chrysene. For instance, its tumorigenic potential seems to vary in a 
dose-dependent manner. Large doses and repeated applications, as well as 
lengthy induction periods, are usually required to obtain significant 
incidences of tumorigenesis, prompting many investigators to classify 
chrysene as a "weak" carcinogen. Further, it seems that chrysene may have 
a greater effect when acting in concert with other, more potent' agents,
i.e., as a tumor-initiator, a synergist, or an "incomplete" carcinogen, 
enhancing tumor formation but lacking the capacity for complete 
carcinogenesis. In one study, chrysene appeared to have inhibited the
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activity of a more potent carcinogen, but this case was contradicted by 
other similar investigations that have produced evidence to the contrary. 
Thus, no generalization can be made regarding chrysene's possible tumor 
"inhibiting" properties. Tests on mammalian cells in culture also have 
produced conflicting results: some investigations have shown chrysene to
produce malignant transformations in a dose-dependent fashion, while others 
have shown it to have a negligible effect. In microbial assays, however, 
chrysene has been mutagenic.
Chrysene's methyl derivatives and certain of their epoxides have been 
shown to possess carcinogenic potential. The 5,6 oxide of chrysene (an 
epoxide) was shown to be less active than chrysene in in vivo tests, but in 
in vitro tests on mammalian cell cultures and in microbial assays, the 
converse was seen. Because such epoxides have been shown to react 
covalently with cellular macromolecules in vitro, they have been postulated 
to be likely candidates for the role of the ultimate carcinogenic 
derivatives of PAH's (Huberman et al., 1972). Several possible 
explanations have been suggested for the lack of epoxide activity in vivo 
as opposed to in vitro. For instance, because of solubility and other 
factors the epoxide may be less able to enter the cell (Boyland and Sims, 
1967), or possibly the high chemical reactivity of such epoxides could 
cause them to react nonspecifically in tissues (with extracellular keratin 
and other molecules) and hence be depleted before reaching and reacting 
with intracellular target macromolecules (Huberman et al., 1972). The 5- 
methylchrysene has been shown to be both a strong, "complete" carcinogen 
and a more active tumor "initiator" than the parent chrysene. One possible
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explanation for the carcinogenic potential of this compound may lie in its 
metabolic activation by the formation of a carbonium ion on the methyl 
group (Marquardt et al., 1972).
Thus, there exists certain evidence indicating that chrysene and its 
derivatives have carcinogenic potential. Additional research is needed to 
elucidate the nature and extent of chrysene's carcinogenic activity and the 
mechanisms whereby such effects may be exerted. No experimental studies 
were found in the literature concerning the inhalation of chrysene as an 
adsórbate on airborne particulate matter, i.e., the mode of entry that 
represents one of the most probable routes of occupational exposure. 
Further, and most importantly, it should be noted that early studies which 
produced negative results for chrysene quite likely used inadequate numbers 
of animals with insufficient periods of observation (Steiner and Falk, 
1951).
IV. CONTROL RECOMMENDATIONS FOR CHRYSENE
A. Engineering Controls
Engineering controls should receive primary emphasis for the reduction 
of occupational exposure to chrysene. Typically, such engineering controls 
include process enclosure. In addition, chrysene work areas, i.e., areas 
where chrysene is manufactured, used, or stored, should be isolated from 
all other work areas. Chrysene work areas should be maintained under 
negative pressure with respect to non-chrysene work areas. This may be
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accomplished by providing continuous local exhaust ventilation so that air 
movement is always from non-chyrsene to chrysene work areas. Exhaust air 
from chrysene work areas, including laboratory gloveboxes, should not be 
discharged into any work area or into the general environment unless it is 
first decontaminated. One means to accomplish this is through the use of 
bag filters in conjunction with the ventilation system. All process 
equipment, including laboratory gloveboxes, should be inspected for leaks 
and other malfunctions on a regular basis. In addition, ventilation 
systems should be tested periodically for their effectiveness, e.g., air 
velocity, static pressure, and air volume.
B. Respiratory Protection
Use of respirators for protection against exposure to chrysene should 
be permitted only during the time period necessary to install feasible 
engineering controls. Two other exceptions would be during nonroutine 
maintenance and repair activities where engineering controls are not 
technologically feasible, and during emergencies.A type C supplied-air 
respirator operated in pressure-demand or other positive pressure modes, or 
self-contained breathing apparatus with a full facepiece operated in 
pressure-demand or other positive pressure modes would provide appropriate 
protection. Respirators should be selected from among those approved by 
the National Institute for Occupational Safety and Health or the Mining 
Enforcement and Safety Administration under the provisions of 30 CFR 11.
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C. Protective Clothing
Employers should provide and ensure that all employees use appropriate 
protective clothing, e.g., coveralls and rubber or latex gloves, to prevent 
skin contact with chrysene during cleanup of spills and during those 
activities described in part B above.
D. Posting of Signs
Entrances to chrysene work areas should be posted with signs 
indicating :
DANGER
AUTHORIZED PERSONNEL ONLY 
CANCER SUSPECT AGENT
E. Work Practices
Procedures for cleanup of spills and disposal of chemical waste should 
be instituted. Persons involved with cleanup activités should wear 
appropriate personal protective equipment and clothing as outlined above. 
Since chrysene crystals can be electrostatic, contaminated surfaces should 
be wetted with clean or soapy water followed by careful wiping with 
disposable towels. All materials collected (including disposable towels) 
should be placed in sealed containers for disposal in a secured sanitary 
landfill, or disposed of in an appropriate incinerator, i.e., one operating
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at high enough temperatures and with sufficiently long contact times for 
complete combustion. General housekeeping and sanitation practices should 
also be established and enforced. Before leaving chrysene work areas at 
the end of each day, employees who have had direct dermal contact with 
chrysene, e.g., through handling, cleanup of spills, or accidents, should 
wash exposed skin areas with soap and water and discard contaminated 
clothing for laundering or disposal. Further, food storage, preparation, 
and consumption should be prohibited in chrysene work areas.
F. Informing Employees of the Hazard
Persons employed in chrysene work areas should be informed of the 
potential hazards of chrysene, including the results of animal 
carcinogenicity and mutagenicity tests.
G. Medical Surveillance
Medical surveillance for workers with potential for exposure to 
chrysene should consist of preplacement examinations and periodic 
evaluations on at least an annual basis.
The history and physical examinations should place emphasis on the 
smoking habits, skin, respiratory tract? and urinary system. Clinical 
testing should include chest x-rays and urinalysis with such other tests as 
sputum cytology carried out as considered appropriate by the responsible 
physician.
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H. Recordkeeping and Availability of Records
Employers should keep accurate records of (1) all measurements taken to 
determine employee exposure to chrysene, (2) measurements demonstrating the 
effectiveness of mechanical ventilation, and (3) all data obtained from 
medical examinations which is pertinent to chrysene exposure. Pertinent 
records from medical examinations should be maintained for at least 30 
years after the worker's employment has ended.
V. SAMPLING AND ANALYTICAL METHODS
A workplace environmental limit for chrysene is not recommended at this 
time. However, in the event that NIOSH should establish such a limit 
(either for chrysene or for the general class of PAH's) in the future, a 
validated sampling and analytical procedure would be required.
NIOSH has not validated a sampling method for chrysene. Chrysene is 
normally encountered as an airborne pollutant (usually adsorbed on airborne 
particulate matter, but sometimes as a vapor) along with numerous other 
PAH's and their derivatives. When chrysene is encountered as a solid or is 
adsorbed on particulate matter, a sampling method similar to the one 
described in the occupational standard for coke oven emissions (29 CFR
1910.1029) would be appropriate.
NIOSH has not validated a specific analytical procedure for chrysene. 
The choice of any particular method depends upon the sample source, the
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amount collected, time constraints, financial constraints, or personal 
preferences. The occupational standard for coke oven emissions (29 CFR
1910.1029) utilizes the benzene-soluble fraction of total particulate 
matter (BSFTPM) as an indicator of worker exposure to PAH's. This 
procedure, however, does not identify individual PAH's. In order to 
identify and quantify individual PAH's, they must first be separated from 
any interfering compounds with which they occur.
Many reviews concerning the state of the art of PAH analysis have 
appeared in the literature, e.g., Sawicki, 1964; Sawicki et al., 1967;
Rutzinger et al., 1973; Zander, 1975. In addition, Appendix A contains a 
list of some analytical methods which have been used to determine the PAH 
content of various compounds.
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Appendix A. Analytical Methods for PAH Determination
PAH Source Method of Separation and/or Analysis
Airborne particulates 
(general environment)













Tobacco and marijuana 
smoke condensates
Single gas chromatographic column
High-resolution liquid chromatography; 
column gas chromatography; ultraviolet 
and fluorescence spectroscopy
Gas chromatography; ultraviolet 
absorption spectroscopy
Gas-liquid chromatography; gas 
chromatography/mass spectrometry
Ultraviolet spectroscopy
Gradient adsorption elution 
chromatography; ultraviolet 
spectroscopy
Ion exchange, gel permeation, and
thin layer chromatography; fluorescence
spectrometry
Fluorescence spectrometry
Gas chromatography/mass spectrometry; 
nuclear magnetic resonance spectrometry
Airborne particulates 
(general environment)
Thin layer chromatography; high pressure 
liquid chromatography
Reference
Lao et al., 1975
Lane et al., 1973 
Novotny et al., 1974
Greinke and Lewis, 1975 
Janini et al., 1976 
Dubois et al., 1972 
Dolansky et al., 1972
Popl et al., 1974
Matsushita & Arashidani, 1976 
Lee et al., 1976
Dong and Locke, 1976










Goal tar pitch volatiles 
Coal liquids
Method of Separation and/or Analysis
Ion exchange and adsorption chromatography; 
mass spectrometry
Ion exchange, gel permeation and thin layer 
chromatography; fluorenscence spectroscopy
Gas chromatography/mass spectrometry with 
computerized data acquisition
Gas chromatography
Adsorption, gradient elution, and gel 
permeation chromatography; fluorescence and 
phosphorescence spectrometry
Reversed-phase high pressure liquid 
chromatography; fluorescence spectroscopy
High-pressure liquid chromatography; 
ultraviolet spectrometry
Matrix - isolation fluorometry
Reference
Jewell et al., 1972
McKay and Latham, 1973
Cautreels and Van 
Cauwenberghe, 1976
Grimmer and Bohnke, 1976
Popl et al., 1975
Rhys Williams and Slavin,
Boden, 1976
Stroupe et al., 1977
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